Search research articles
Contact Us
Filters
Showing results (111-120 of 191) with videos related to
Page
of 20
Sort By:
The Lancet. Haematology
|
August 28, 2020
Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial
Catherine S Diefenbach, Fangxin Hong, Richard F Ambinder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2023
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse
Laura E Hogan, Patrick A Brown, Lingyun Ji, et al.
Clinical Pharmacology and Therapeutics
|
February 15, 2023
The Association Between Baseline Hepatic or Renal Function and Clinical Outcomes for Patients With Non-Small Cell Lung Cancer Treated With a PD-1/PD-L1 Blocking Antibody Using Real-World and Trial Data
Qi Liu, Raina Mathur, Yuan Xu, et al.
Cancer Communications (London, England)
|
May 22, 2025
A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
JCO Oncology Practice
|
June 23, 2026
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy
Megan Othus, Thach-Giao Truong, Elad Sharon, et al.
Journal of Gynecologic Oncology
|
April 17, 2026
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: vaginal cancer sub cohort results
Young Kwang Chae, Josie Czeskleba, Sandip Pravin Patel, et al.
Cytotherapy
|
February 27, 2022
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials
Mark D Stewart, Bruce McCall, Marcelo Pasquini, et al.
The Lancet. Haematology
|
August 2, 2023
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
Paul G Rubinstein, Page C Moore, Milan Bimali, et al.
Chest
|
May 29, 2020
Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study
Anish Thomas, Idrees Mian, Camille Tlemsani, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review
Benjamin P Geisler, Lara Zahabi, Adam E Lang, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 191) with videos related to
Sort By:
Page
of 20
The Lancet. Haematology
|
August 28, 2020
Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial
Catherine S Diefenbach, Fangxin Hong, Richard F Ambinder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2023
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse
Laura E Hogan, Patrick A Brown, Lingyun Ji, et al.
Clinical Pharmacology and Therapeutics
|
February 15, 2023
The Association Between Baseline Hepatic or Renal Function and Clinical Outcomes for Patients With Non-Small Cell Lung Cancer Treated With a PD-1/PD-L1 Blocking Antibody Using Real-World and Trial Data
Qi Liu, Raina Mathur, Yuan Xu, et al.
Cancer Communications (London, England)
|
May 22, 2025
A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
JCO Oncology Practice
|
June 23, 2026
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy
Megan Othus, Thach-Giao Truong, Elad Sharon, et al.
Journal of Gynecologic Oncology
|
April 17, 2026
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: vaginal cancer sub cohort results
Young Kwang Chae, Josie Czeskleba, Sandip Pravin Patel, et al.
Cytotherapy
|
February 27, 2022
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials
Mark D Stewart, Bruce McCall, Marcelo Pasquini, et al.
The Lancet. Haematology
|
August 2, 2023
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
Paul G Rubinstein, Page C Moore, Milan Bimali, et al.
Chest
|
May 29, 2020
Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study
Anish Thomas, Idrees Mian, Camille Tlemsani, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review
Benjamin P Geisler, Lara Zahabi, Adam E Lang, et al.
Page
of 20